Bharat Biotech gets nod for Phase 3 trials of intranasal vaccine
JNS: The subject expert committee (SEC) of Drugs controller General of India (DCGI) has recommended that Hyderabad-based Bharat Biotech can conduct phase- three trials on its intranasal vaccine. The company …
Bharat Biotech gets nod for Phase 3 trials of intranasal vaccine Read More